Aptose Biosciences, Inc. ( APTO) - Stock Earnings
Stock symbol APTO is outdated, potentially delisted? Maybe it is available on other exchange?
APTO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -13.1 million USD | — USD |
| 2023Q2 | -14.1 million USD | — USD |
| 2023Q3 | -11.4 million USD | — USD |
APTO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -65.3 million USD | 0 USD |
| 2022 | -41.1 million USD | 0 USD |
| 2023 | -49.3 million USD | — USD |
APTO
Price: $1.71
52 week price:
Earnings Per Share: -36.38 USD
P/E Ratio: -0.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 268562
Ebitda: -2.7 millionMarket Capitalization: 4.4 million